Context Therapeutics Inc. (CNTX)
About Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$36.1M
- Total assets
- $68.5M
- Market cap
- $160.8M
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Operating income
- -$39.7M
- Income tax
- $0
- Net income
- -$36.1M
- EPS (basic)
- $-0.38
- EPS (diluted)
- $-0.38
Balance sheet
- Total assets
- $68.5M
- Current assets
- $68.4M
- Total liabilities
- $8.0M
- Current liabilities
- $8.0M
- Shareholders’ equity
- $60.5M
Cash flow
- Operating cash flow
- -$26.4M
- Investing cash flow
- -$2.0M
- Financing cash flow
- -$15.3K
- Net cash flow
- -$28.4M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $160.8M
- EPS (diluted)
- $-0.38
- Shares outstanding
- 263.6M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Oct 20, 2021
Context Therapeutics Inc. (CNTX) Stock Price
- Reported a net loss of $36.1M.
- Trading 82% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Context Therapeutics Inc..
Write a review
News about Context Therapeutics Inc.
News & sentiment via Polygon.io
Context Therapeutics Inc.: frequently asked questions
Is Context Therapeutics Inc. an American company?
Context Therapeutics Inc. is a US-based company headquartered in Philadelphia, Pennsylvania, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Context Therapeutics Inc. headquartered?
Context Therapeutics Inc. is headquartered in Philadelphia, Pennsylvania, United States.
Is Context Therapeutics Inc. publicly traded?
Yes — Context Therapeutics Inc. is a publicly traded company. Its stock trades under the ticker symbol CNTX on the NASDAQ.
What does Context Therapeutics Inc. do?
Context Therapeutics Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
